ReWalk Robotics Stock (NASDAQ:RWLK)
Previous Close
$0.99
52W Range
$0.56 - $1.30
50D Avg
$0.88
200D Avg
$0.74
Market Cap
$63.03M
Avg Vol (3M)
$325.95K
Beta
2.31
Div Yield
-
RWLK Company Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
RWLK Performance
Peer Comparison
Ticker | Company |
---|---|
RPID | Rapid Micro Biosystems, Inc. |
ICCM | IceCure Medical Ltd |
SGHT | Sight Sciences, Inc. |
LNSR | LENSAR, Inc. |
SSKN | STRATA Skin Sciences, Inc. |
VAPO | Vapotherm, Inc. |
TIVC | Tivic Health Systems, Inc. |
NUWE | Nuwellis, Inc. |
NPCE | NeuroPace, Inc. |
SRDX | Surmodics, Inc. |
OSA | ProSomnus, Inc. Common Stock |
BBLG | Bone Biologics Corporation |
BJDX | Bluejay Diagnostics, Inc. |
HSCS | Heart Test Laboratories, Inc. |
TNON | Tenon Medical, Inc. |
VVOS | Vivos Therapeutics, Inc. |
NAOV | NanoVibronix, Inc. |